Sidley is pleased to announce that Carlton Fleming has joined the firm as a partner in the Corporate and Capital Markets practices in San Francisco, with a focus on representing leading life sciences and technology companies. Mr. Fleming will be a member of Sidley’s award-winning Global Life Sciences practice. He was previously a partner at Cooley LLP.

Mr. Fleming represents high-growth private and public life sciences and technology companies in private financings, public offerings, SEC reporting and compliance, and corporate governance. He has been involved in over 60 IPOs and other public offerings during his career. He also regularly advises corporate clients and their boards of directors and special committees on a wide variety of securities law and corporate governance matters.

“This addition continues the expansion of our market-leading life sciences and technology transactional practices, with deep industry knowledge across multiple industries and transactions,” said Sharon Flanagan, a member of the firm’s Management Committee and the firm’s 200-lawyer Global Life Sciences practice. “Carlton’s experience working on a variety of financing and capital markets transactions for life sciences and technology companies at all stages of growth will be a great addition to our global multidisciplinary team.”

“As our seventh new corporate partner in a little over a year, Carlton substantially strengthens our capital markets and public company practice in Northern California,” said Martin Wellington, managing partner of Sidley’s Palo Alto office and co-head of the Northern California corporate practice. “We are excited to continue to expand our life sciences and technology-focused transactional practices with another outstanding corporate partner.”